Search research articles
Contact Us
Filters
Showing results (131-140 of 137) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 137 results.
European Heart Journal
|
November 23, 2014
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure
John McMurray, Milton Packer, Akshay Desai, et al.
The New England Journal of Medicine
|
August 28, 2012
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
Matthew T Roe, Paul W Armstrong, Keith A A Fox, et al.
The New England Journal of Medicine
|
August 26, 2022
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Scott D Solomon, John J V McMurray, Brian Claggett, et al.
The New England Journal of Medicine
|
March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events
, John J McMurray, Rury R Holman, et al.
Circulation
|
November 19, 2014
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure
Milton Packer, John J V McMurray, Akshay S Desai, et al.
The New England Journal of Medicine
|
March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events
, Rury R Holman, Steven M Haffner, et al.
Circulation. Heart Failure
|
July 8, 2018
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial
Scott D Solomon, Adel R Rizkala, Martin P Lefkowitz, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 137) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 137 results.
European Heart Journal
|
November 23, 2014
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure
John McMurray, Milton Packer, Akshay Desai, et al.
The New England Journal of Medicine
|
August 28, 2012
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
Matthew T Roe, Paul W Armstrong, Keith A A Fox, et al.
The New England Journal of Medicine
|
August 26, 2022
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Scott D Solomon, John J V McMurray, Brian Claggett, et al.
The New England Journal of Medicine
|
March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events
, John J McMurray, Rury R Holman, et al.
Circulation
|
November 19, 2014
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure
Milton Packer, John J V McMurray, Akshay S Desai, et al.
The New England Journal of Medicine
|
March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events
, Rury R Holman, Steven M Haffner, et al.
Circulation. Heart Failure
|
July 8, 2018
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial
Scott D Solomon, Adel R Rizkala, Martin P Lefkowitz, et al.
Page
of 14